Contract Manufacturing Industry News

91. Dr. Reddy's Announces The Launch Of Amlodipine Besylate And Benazepril Hydrochloride Capsules 7/7/2011
    Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Amlodipine Besylate and Benazepril Hydrochloride capsules (5 mg/40 mg and 10 mg/40 mg), a bioequivalent generic version of LOTREL®* capsules in the US market on July 5, 2011, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Amlodipine Besylate and Benazepril Hydrochloride capsules.
92. JHP Pharmaceuticals Enters Agreement To Produce Life-Saving Drug 7/6/2011

    JHP Pharmaceuticals, a leading provider of contract manufacturing services for sterile injectable products has entered into an agreement with an undisclosed pharmaceutical company. The agreement is for the product transfer and registration batch production of a life-saving drug.

93. Lonza's New GS System Medium And Feed Platform Reaches 10g/L 6/30/2011
    Lonza is launching a new cell culture medium and feed platform for the GS Gene Expression System that achieves product yields up to 10g/L.
94. inVentiv Health Completes Acquisition Of i3 6/16/2011
    inVentiv Health, Inc., offering best-in-class clinical, consulting and commercial services to the healthcare industry, recently announced it has completed the acquisition of i3, a top-tier contract research organization (CRO) to the pharmaceutical, biotech and medical device industries.
95. Dr. Reddy's Announces Three Generic Product Launches In The US Market 6/8/2011
    Donepezil Hydrochloride tablets (5mg and 10mg strengths), a bioequivalent generic version of ARICEPT tablets. The Food & Drug Administration (FDA) approved Dr. Reddy’s ANDA for Donepezil HCl tablets on May 31, 2011. Both strengths of Dr. Reddy’s Donepezil Hydrochloride tablets are available in 30, 90 and 500 count bottles.
96. Lonza To Expand In Singapore 6/8/2011
    Lonza is investing CHF 10 million to expand its biopharmaceutical development services platform in Singapore.
97. Ashland To Acquire International Specialty Products Inc. (ISP); Broadens Global Leadership In Specialty Chemicals 6/6/2011
    Ashland Inc. and International Specialty Products Inc. (ISP) recently announced that Ashland has agreed to acquire privately owned ISP, a global specialty chemical manufacturer of innovative functional ingredients and technologies.
98. inVentiv Health To Acquire PharmaNet 5/19/2011
    inVentiv Health, offering best-in-class clinical, consulting and commercial services to the healthcare industry, recently announced it has signed a definitive agreement to purchase PharmaNet Development Group, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug and medical device industries.
99. Almac Introduces selectAZyme 5/10/2011
    As anticipated, Almac’s biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of kgs of chiral intermediates for drug substance manufacture, regular enzyme supply to specialty chemical companies and continued growth of its screening kits offering.
100. Single-Use Tubing And Filter/Tubing Assemblies 4/27/2011
     Meissner’s BioFlex™ fluid path assemblies are designed for secure fluid transfer in critical biopharmaceutical processing applications. These single-use tubing and filter/tubing assemblies offer maximum convenience and flexibility in single-use systems.